Tissue Determinants of Antiviral Immunity in the Liver
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
The liver is an organ bearing important metabolic and immune functions. Hepatocytes are the main metabolically active cells of the liver and are the target of infection by hepatotropic viruses. Virus-specific CD8 T cells are essential for the control of hepatocyte infection with hepatotropic viruses but may be subject to local regulation of their effector function. Here, we review our current knowledge of the tissue determinants of antiviral immunity in the liver. Liver Sinusoidal Endothelial Cells (LSECs) not only allow through their fenestrations the access of circulating virus-specific CD8 T cells to engage in direct contact with infected hepatocytes without the need for extravasation but also cross-present viral antigens released from infected hepatocytes to these CD8 T cells. Two important features of LSECs and hepatocytes contribute to antiviral immune surveillance and liver failure. First, CD8 T cell immunity targeting LSECs leads to widespread endothelial cell death and results in sinusoidal microcirculation failure, causing fulminant viral hepatitis, whereas immune-mediated loss of hepatocytes is rapidly compensated by the regenerative capacity of the liver. Second, virus-infected hepatocytes support clearance of infection by responding to TNF, which is released from virus-specific CD8 T cells, with the selective induction of apoptosis. This increased sensitivity for TNF-induced death is caused by reduced mitochondrial resilience in virus-infected hepatocytes and may assist antiviral immunity in preferential targeting of virus-infected hepatocytes. Thus, hepatocytes and LSECs actively contribute to the outcome of antiviral CD8 T cell immunity in the liver. The knowledge of the mechanisms determining CD8 T cell control of hepatotropic viral infection will help to improve strategies to increase antiviral immune surveillance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Although hepatocytes can present antigens to T cells through MHC-I [94, 95] and trigger antiviral immune responses after murine hepatitis virus B infection [94, 96, 97], the efficacy of local priming in the liver for virus-specific CD8 + T-cell immunity is low, often leading to dysfunctional CD8 + T cells [98, 99].”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · doi:10.1038/s41423-025-01313-7 · cites this paper as [99]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Batf3 Deficiency Reveals a Critical Role for CD8α + Dendritic Cells in Cytotoxic T Cell Immunity
Hildner, K., Edelson, B. T., Purtha, W. E., Diamond, M., Matsushita, H., Kohyama, M., Calderon, B., Schraml, B. U., Unanue, E. R., Diamond, M. S., et al. (2008) · Science · doi:10.1126/science.1164206 · Cited by 2,081 · cited 1×
“These DCs are characterized by the expression of CD8, CD102 and XCR1 and rely on the transcription factors basic leucine zipper ATF-like transcription factor 3 (BATF3) and interferon regulatory factor 8 (IRF8) [18, 19].”
Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter
Baughman, J. M., Perocchi, F., Girgis, H. S., Plovanich, M., Belcher-Timme, C. A., Sancak, Y., Bao, X. R., Strittmatter, L., Goldberger, O., Bogorad, R. L., et al. (2011) · Nature · doi:10.1038/nature10234 · Cited by 1,906 · cited 1×
“Notwithstanding the many recognized forms of mitochondrial calcium uptake and storage [53, 54, 55], we still lack a mechanistic understanding of how viral infection of hepatocytes causes the loss of mitochondrial resilience to calcium challenge.”
Jung, S., Unutmaz, D., Wong, P., Sano, G.-I., De los Santos, K., Sparwasser, T., Wu, S., Vuthoori, S., Ko, K., Zavala, F., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00365-5 · Cited by 1,773 · cited 1×
“The process of presenting exogenous antigens on MHC I molecules to induce protective immunity is restricted mainly to APCs and is termed cross-priming [15, 16, 17] ( ▶ Fig.1B ).”
CD8+ T Cells: Foot Soldiers of the Immune System
Zhang, N., & Bevan, M. J. (2011) · Immunity · doi:10.1016/j.immuni.2011.07.010 · Cited by 1,088 · cited 1×
“Notwithstanding the important role of Interferon-gamma in improving the cytotoxic effector function of CD8T cells [41], it does not have a direct death-inducing effect on virus-infected hepatocytes.”
Newton, K., Strasser, A., Kayagaki, N., & Dixit, V. M. (2024) · Cell · doi:10.1016/j.cell.2023.11.044 · Cited by 990 · cited 1×
“Many forms of cell death have been identified [49], but TNF-induced death in virus-infected hepatocytes occurr-ed exclusively by apoptosis and not by other forms of cell death such as pyroptosis, necroptosis, ferroptosis or oxeiptosis [42].”
Crispe, I. N. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132629 · Cited by 986 · cited 1×
“To prevent continuous immune stimulation by toxins and bacterial degradation products that serve as pattern recognition receptor (PRR)-ligands, the liver has evolved numerous strategies to dampen those immune immunostimulatory signals [1, 2, 3].”
Thimme, R., Wieland, S., Steiger, C., Ghrayeb, J., Reimann, K. A., Purcell, R. H., & Chisari, F. V. (2003) · Journal of Virology · doi:10.1128/jvi.77.1.68-76.2003 · Cited by 979 · cited 1×
“%) in a CD8T cell-dependent manner, it is still not entirely known why some patients fail to eradicate the virus [10, 11, 12, 13, 14].”
The machineries, regulation and cellular functions of mitochondrial calcium
Giorgi, C., Marchi, S., & Pinton, P. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0052-8 · Cited by 941 · cited 1×
“Notwithstanding the many recognized forms of mitochondrial calcium uptake and storage [53, 54, 55], we still lack a mechanistic understanding of how viral infection of hepatocytes causes the loss of mitochondrial resilience to calcium challenge.”
Antigen-presenting cell function in the tolerogenic liver environment
Thomson, A. W., & Knolle, P. A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2858 · Cited by 805 · cited 1×
“To prevent continuous immune stimulation by toxins and bacterial degradation products that serve as pattern recognition receptor (PRR)-ligands, the liver has evolved numerous strategies to dampen those immune immunostimulatory signals [1, 2, 3].”
Self-citationNucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
Gane, E. J., Stedman, C. A., Hyland, R. H., Ding, X., Svarovskaia, E., Symonds, W. T., Hindes, R. G., & Berrey, M. M. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208953 · Cited by 764 · cited 1×
“…C, a curative directly acting antiviral therapy exists, chronic hepatitis B can currently only be treated with nucleo(s)tide analogues, suppressing viral replication but not leading to a final cure from infection because of HBV establishes an extrachromosomal persistence form, the cccDNA [7].”
Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review
Braet, F., & Wisse, E. (2002) · Comparative Hepatology · doi:10.1186/1476-5926-1-1 · Cited by 753 · cited 2×
“The small diameter and the low blood flow in the liver sinusoids facilitate the adhesion of CD8T cells to sinusoidal cell populations [33].”
Kurts, C., Kosaka, H., Carbone, F. R., Miller, J. F. A. P., & Heath, W. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.239 · Cited by 706 · cited 1×
“The process of presenting exogenous antigens on MHC I molecules to induce protective immunity is restricted mainly to APCs and is termed cross-priming [15, 16, 17] ( ▶ Fig.1B ).”
ESCRT-III Acts Downstream of MLKL to Regulate Necroptotic Cell Death and Its Consequences
Gong, Y.-N., Guy, C., Olauson, H., Becker, J. U., Yang, M., Fitzgerald, P., Linkermann, A., & Green, D. R. (2017) · Cell · doi:10.1016/j.cell.2017.03.020 · Cited by 689
Local control of the immune response in the liver
Knolle, P. A., & Gerken, G. (2000) · Immunological Reviews · doi:10.1034/j.1600-0528.2002.017408.x · Cited by 603 · cited 1×
“To prevent continuous immune stimulation by toxins and bacterial degradation products that serve as pattern recognition receptor (PRR)-ligands, the liver has evolved numerous strategies to dampen those immune immunostimulatory signals [1, 2, 3].”
Self-citationXIAP discriminates between type I and type II FAS-induced apoptosis
Jost, P. J., Grabow, S., Gray, D., McKenzie, M. D., Nachbur, U., Huang, D. C. S., Bouillet, P., Thomas, H. E., Borner, C., Silke, J., et al. (2009) · Nature · doi:10.1038/nature08229 · Cited by 482 · cited 1×
“He-patocytes contain more than 1000 mitochondria to secure the energy supply for their high metabolic demands [50], and require the involvement of mitochondria for the induction of apoptosis [51].”
Stealth and Cunning: Hepatitis B and Hepatitis C Viruses
Wieland, S. F., & Chisari, F. V. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9369-9380.2005 · Cited by 457 · cited 1×
“It is important to note that these interactions do not require local inflammation, which is of special interest, as, for example, HBV infection does not induce any inflammation during viral infection or replication [36].”
Detection of Microbial Infections Through Innate Immune Sensing of Nucleic Acids
Tan, X., Sun, L., Chen, J., & Chen, Z. J. (2018) · Annual Review of Microbiology · doi:10.1146/annurev-micro-102215-095605 · Cited by 443
Cross-priming in health and disease
Kurts, C., Robinson, B. W. S., & Knolle, P. A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2780 · Cited by 429 · cited 2×
“The process of presenting exogenous antigens on MHC I molecules to induce protective immunity is restricted mainly to APCs and is termed cross-priming [15, 16, 17] ( ▶ Fig.1B ).”
Self-citationEnjoy the Trip: Calcium in Mitochondria Back and Forth
De Stefani, D., Rizzuto, R., & Pozzan, T. (2016) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-034216 · Cited by 423
Wong, J., Johnston, B., Lee, S. S., Bullard, D. C., Smith, C. W., Beaudet, A. L., & Kubes, P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119468 · Cited by 392 · cited 1×
“Because of these unique conditions, adhesion of CD8T cells does not require the expression of the otherwise needed selectins [34].”
Warren, A., Le Couteur, D. G., Fraser, R., Bowen, D. G., McCaughan, G. W., & Bertolino, P. (2006) · Hepatology · doi:10.1002/hep.21378 · Cited by 347
Fisicaro, P., Barili, V., Montanini, B., Acerbi, G., Ferracin, M., Guerrieri, F., Salerno, D., Boni, C., Massari, M., Cavallo, M. C., et al. (2017) · Nature Medicine · doi:10.1038/nm.4275 · Cited by 341
Robust Anti-Viral Immunity Requires Multiple Distinct T Cell-Dendritic Cell Interactions
Eickhoff, S., Brewitz, A., Gerner, M. Y., Klauschen, F., Komander, K., Hemmi, H., Garbi, N., Kaisho, T., Germain, R. N., & Kastenmüller, W. (2015) · Cell · doi:10.1016/j.cell.2015.08.004 · Cited by 337 · cited 1×
“These DCs are characterized by the expression of CD8, CD102 and XCR1 and rely on the transcription factors basic leucine zipper ATF-like transcription factor 3 (BATF3) and interferon regulatory factor 8 (IRF8) [18, 19].”
Global Elimination of Chronic Hepatitis
Thomas, D. L. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1810477 · Cited by 325 · cited 1×
“300 million chronic hepatitis B patients worldwide [8, 9].”
Immunosurveillance of the Liver by Intravascular Effector CD8 + T Cells
Guidotti, L. G., Inverso, D., Sironi, L., Di Lucia, P., Fioravanti, J., Ganzer, L., Fiocchi, A., Vacca, M., Aiolfi, R., Sammicheli, S., et al. (2015) · Cell · doi:10.1016/j.cell.2015.03.005 · Cited by 323 · cited 2×
“…the antiviral immune response in HBV infection, cytotoxic CD8T cells attach to platelet aggregates forming in the liver sinusoids and are then triggered to perform effector function, i.e. killing of HBV-infected hepatocytes through their cellular protrusions reaching through the fe-nestrae [12].”
Mechanisms and dynamics of T cell-mediated cytotoxicity in vivo
Halle, S., Halle, O., & Förster, R. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.04.002 · Cited by 302 · cited 1×
“However, hepatocytes are large cells that may require several CD8T cells to achieve killing [40], pointing towards mechanisms that may help virus-specific CD8T cells to kill virus-infected hepatocytes.”
Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells
Pallett, L. J., Gill, U. S., Quaglia, A., Sinclair, L. V., Jover-Cobos, M., Schurich, A., Singh, K. P., Thomas, N., Das, A., Chen, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3856 · Cited by 279 · cited 2×
“Moreover, regulatory immune cell populations such as myeloid-derived suppressor cells downregulate the function of CD8T cell immunity locally in the liver [11, 32].”
Hepatocytes induce functional activation of naive CD8+ T lymphocytes but fail to promote survival
Bertolino, P., Trescol-Biémont, M.-C., & Rabourdin-Combe, C. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199801)28:01<221::aid-immu221>3.0.co;2-f · Cited by 237 · cited 1×
“First reports have shown that hepatocytes can prime naive CD8T cells with the outcome of BCL-2 interacting meditator of cell death (BIM)-dependent cell death [26, 27].”
Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity
Weigelin, B., den Boer, A. T., Wagena, E., Broen, K., Dolstra, H., de Boer, R. J., Figdor, C. G., Textor, J., & Friedl, P. (2021) · Nature Communications · doi:10.1038/s41467-021-25282-3 · Cited by 234 · cited 1×
“CD8T cells have been demonstrated to be capable of serial killing of target cells [39].”
The scavenger endothelial cell: a new player in homeostasis and immunity
Sørensen, K. K., McCourt, P., Berg, T., Crossley, C., Couteur, D. L., Wake, K., & Smedsrød, B. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00686.2011 · Cited by 233
Regulatory myeloid cells paralyze T cells through cell–cell transfer of the metabolite methylglyoxal
Baumann, T., Dunkel, A., Schmid, C., Schmitt, S., Hiltensperger, M., Lohr, K., Laketa, V., Donakonda, S., Ahting, U., Lorenz-Depiereux, B., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0666-9 · Cited by 225 · cited 1×
“Moreover, regulatory immune cell populations such as myeloid-derived suppressor cells downregulate the function of CD8T cell immunity locally in the liver [11, 32].”
Self-citationDynamics and genomic landscape of CD8+ T cells undergoing hepatic priming
Bénéchet, A. P., De Simone, G., Di Lucia, P., Cilenti, F., Barbiera, G., Le Bert, N., Fumagalli, V., Lusito, E., Moalli, F., Bianchessi, V., et al. (2019) · Nature · doi:10.1038/s41586-019-1620-6 · Cited by 222 · cited 3×
“These dysfunctional CD8T cells do not respond to classical checkpoint inhibition with anti-PD-L1 antibodies but respond to IL-2 signaling, which might indicate strategies to overcome CD8T cell dysfunc-tionality and lead to viral eradication in infected hepatocytes [14].”
Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees
Wieland, S. F., Spangenberg, H. C., Thimme, R., Purcell, R. H., & Chisari, F. V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308478100 · Cited by 219 · cited 1×
“In contrast, successful antiviral immunity was associated with an influx of HBV-specific cytotoxic CD8T cells into the liver of HBV-infected chimpanzees, which might be primed in secondary lymphoid tissue [31].”
Wiesner, R. J., Rüegg, J. C., & Morano, I. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90517-o · Cited by 197 · cited 1×
“He-patocytes contain more than 1000 mitochondria to secure the energy supply for their high metabolic demands [50], and require the involvement of mitochondria for the induction of apoptosis [51].”
Carambia, A., Freund, B., Schwinge, D., Bruns, O. T., Salmen, S. C., Ittrich, H., Reimer, R., Heine, M., Huber, S., Waurisch, C., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.01.006 · Cited by 181
Hepatocyte entry leads to degradation of autoreactive CD8 T cells
Benseler, V., Warren, A., Vo, M., Holz, L. E., Tay, S. S., Le Couteur, D. G., Breen, E., Allison, A. C., van Rooijen, N., McGuffog, C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112251108 · Cited by 164
De Simone, G., Andreata, F., Bleriot, C., Fumagalli, V., Laura, C., Garcia-Manteiga, J. M., Di Lucia, P., Gilotto, S., Ficht, X., De Ponti, F. F., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.05.005 · Cited by 154
ESCRT-mediated membrane repair protects tumor-derived cells against T cell attack
Ritter, A. T., Shtengel, G., Xu, C. S., Weigel, A., Hoffman, D. P., Freeman, M., Iyer, N., Alivodej, N., Ackerman, D., Voskoboinik, I., et al. (2022) · Science · doi:10.1126/science.abl3855 · Cited by 137 · cited 1×
“The killing of parenchymal cells may not be easy for effector CD8T cells because target cells defend themselves from induction of cell death through endosomal sorting complexes required for transport (ESCRT)-mediated membrane repair [45, 46].”
Holz, L. E., Benseler, V., Bowen, D. G., Bouillet, P., Strasser, A., O'Reilly, L., d'Avigdor, W. M. H., Bishop, A. G., McCaughan, G. W., & Bertolino, P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.078 · Cited by 127
Inhibition of inflammatory CD4 T cell activity by murine liver sinusoidal endothelial cells
Carambia, A., Frenzel, C., Bruns†, O. T., Schwinge, D., Reimer, R., Hohenberg, H., Huber, S., Tiegs, G., Schramm, C., Lohse, A. W., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.09.008 · Cited by 121
NF-κB determines between apoptosis and proliferation in hepatocytes during liver regeneration
Plümpe, J., Malek, N. P., Bock, C.-T., Rakemann, T., Manns, M. P., & Trautwein, C. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.1.g173 · Cited by 95
Virally Infected Mouse Liver Endothelial Cells Trigger CD8+ T-Cell Immunity
Kern, M., Popov, A., Scholz, K., Schumak, B., Djandji, D., Limmer, A., Eggle, D., Sacher, T., Zawatzky, R., Holtappels, R., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.057 · Cited by 85 · cited 1×
“Interestingly, priming of CD8T cells by virus-infected LSEC leads to a cytotoxic CD8T cell phenotype in vitro [25].”
Self-citationCostello, R. T., Mallet, F., Sainty, D., Maraninchi, D., Gastaut, J.-A., & Olive, D. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199801)28:01<90::aid-immu90>3.0.co;2-5 · Cited by 81
The global burden of viral hepatitis: better estimates to guide hepatitis elimination efforts
Wiktor, S. Z., & Hutin, Y. J. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31018-2 · Cited by 78 · cited 1×
“300 million chronic hepatitis B patients worldwide [8, 9].”
Fulminant Adenovirus Hepatitis Following Bone Marrow Transplantation
Wang, W. H., & Wang, H. L. (2003) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2003-127-e246-fahfbm · Cited by 77
Böttcher, J. P., Schanz, O., Wohlleber, D., Abdullah, Z., Debey-Pascher, S., Staratschek-Jox, A., Höchst, B., Hegenbarth, S., Grell, J., Limmer, A., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.02.008 · Cited by 76
Self-citationTNF-Induced Target Cell Killing by CTL Activated through Cross-Presentation
Wohlleber, D., Kashkar, H., Gärtner, K., Frings, M. K., Odenthal, M., Hegenbarth, S., Börner, C., Arnold, B., Hämmerling, G., Nieswandt, B., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.08.001 · Cited by 69 · cited 2×
“Cross-presentation of viral antigens, which were initially released from hepatocytes, on MHC I molecules by LSEC and subsequent activation of virus-specific CD8T cells can thus induce the killing of virus-infected hepatocytes, which we termed non-canonical CD8T cell effector function [43].”
Self-citationCD8+ T cell tolerance following antigen recognition on hepatocytes
Holz, L. E., Warren, A., Couteur, D. G. L., Bowen, D. G., & Bertolino, P. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.08.005 · Cited by 48 · cited 1×
“This has led to the speculation that HCV-specific CD8T cells might be primed by HCV-infected hepatocytes rather than by professional antigen-presenting cells [29].”
Gainey, M., Rivenbark, J. G., Cho, H., Yang, L.-P., & Yokoyama, W. (2012) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1217111109 · Cited by 48 · cited 1×
“Such killing by effector CD8T cell can occur in the absence of MHC I-restricted activation by the target cell [43] and, therefore, may also operate in situations where virus-infection leads to downregulation of MHC I molecules, as observed for DNA viruses like herpes virus [44].”
Perforin inhibition protects from lethal endothelial damage during fulminant viral hepatitis
Welz, M., Eickhoff, S., Abdullah, Z., Trebicka, J., Gartlan, K. H., Spicer, J. A., Demetris, A. J., Akhlaghi, H., Anton, M., Manske, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07213-x · Cited by 41 · cited 3×
“Nota-bly, fulminant liver failure from CD8T cells recognizing their cognate antigen on LSECs cross-presenting viral antigens from infected hepatocytes is caused by widespread failure of sinusoidal blood flow [37].”
InfluentialSelf-citationHepatic manifestations of Epstein-Barr viral infection
Méndez‐Sánchez, N., Aguilar-Domínguez, C., Chávez-Tapia, N. C., & Uribe, M. (2005) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32068-x · Cited by 33 · cited 1×
“Other viruses, like Cytomegalovirus (CMV), Epstein-Barr-virus (EBV) or adeno-viruses (AdV), can also infect the liver, but those infections are less frequent compared to hepatitis virus infections [4, 5, 6].”
Liver sinusoidal endothelial cell cross-priming is supported by CD4 T cell-derived IL-2
Wittlich, M. M., Dudek, M., Böttcher, J. P., Schanz, O., Hegenbarth, S. I., Bopp, T., Schmitt, E., Kurts, C., Garbers, C., Rose‐John, S., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.12.015 · Cited by 27
Self-citationCytomegalovirus-Induced Hepatitis in an Immunocompetent Patient
Das, A. (2014) · American Journal of Case Reports · doi:10.12659/ajcr.890945 · Cited by 24 · cited 1×
“Other viruses, like Cytomegalovirus (CMV), Epstein-Barr-virus (EBV) or adeno-viruses (AdV), can also infect the liver, but those infections are less frequent compared to hepatitis virus infections [4, 5, 6].”
Schneider, A., Kurz, S., Manske, K., Janas, M. K., Heikenwälder, M. F., Misgeld, T., Aichler, M., Weissmann, S. F., Zischka, H., Knolle, P. A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-44922-9 · Cited by 24 · cited 1×
“Analysis of hepatocyte mitochondria at the single organelle level revealed subtle changes after infection, in particular, a lower membrane potential [52].”
Self-citationLampl, S., Janas, M. K., Donakonda, S., Brugger, M., Lohr, K., Schneider, A., Manske, K., Sperl, L. E., Klaeger, S., Küster, B., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.06.026 · Cited by 18 · cited 7×
“Indeed, a comprehensive analysis of virus-infected hepatocytes identified mitochondria as the central hubs within infected hepatocytes that interconnected metabolic changes from virus replication with apoptotic signaling downstream of the TNF receptor [42].”
InfluentialSelf-citationManske, K., Schneider, A., Ko, C., Knolle, P. A., Steiger, K., Protzer, U., & Wohlleber, D. (2021) · Viruses · doi:10.3390/v13112273 · Cited by 2 · cited 2×
“Numbers can be as high as 10 6 virus-specific CD8T cells per g liver tissue in preclinical models of hepa-totropic virus infection [38].”
Self-citation
Cited by
(2025) · doi:10.1038/s41423-025-01313-7 · Cited by 97
“Suicidal emperipolesis has been investigated primarily in the context of autoreactive T cells in autoimmune hepatitis but may also contribute to tolerogenic environments in other settings, such as viral hepatitis [94, 99].”
InfluentialYe, Y., Cao, M., Su, Y., Zhou, W., & Li, Y. (2026) · BMC Pediatrics · doi:10.1186/s12887-026-06846-y
Shu, Y., Yan, H., Sun, H., Gu, X., Littwitz-Salomon, E., Liu, J., Wu, J., Yang, D., Zheng, X., Lu, M., et al. (2026) · Liver International · doi:10.1111/liv.70864
“…cytokine release are not only statistically robust but also biologically relevant, as diminished cytokine secretion from hepatic sinusoidal endothelium is sufficient to blunt the local antiviral T cell response within the liver sinusoidal niche during persistent HBV replication [42, 43].”
Isolation, identification, and pathogenicity of Novel Duck Reovirus strain from ducklings in China
Wang, Z., Tan, J., Xi, H., Hu, Y., Lei, X., Tan, M., Wei, J., Lin, C., Zhang, F., Zeng, Y., et al. (2026) · Poultry Science · doi:10.1016/j.psj.2026.107834
Metadata
- Authors
- Wohlleber, D., & Knolle, P. A.
- Affiliations
- Technical University of Munich (DE)
- German Center for Infection Research (DE)
- Corresponding author
- Wohlleber, Dirk
- Venue
- Zeitschrift für Gastroenterologie
- Publisher
- Georg Thieme Verlag KG
- Published
- 2025-01
- Volume
- 63
- Issue
- 01
- Pages
- 65-72
- ISSN
- 0044-2771 (ISSN-L)
- 1439-7803
- PMC
- PMC11723797
- OpenAlex
- W4406255904
- Cited by
- 3
- References
- 55
- Citations by year
- 2026: 2 · 2025: 1
- FWCI
- 0.46
- Type
- journal article
- Language
- de
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Zeitschrift für Gastroenterologie (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (272983813 - TRR179)
- Topics
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Keywords
- antiviral immunity, liver, hepatotropic viruses, CD8+ T cells, liver sinusoidal endothelial cells, hepatocytes, cross-presentation, viral hepatitis, liver failure, TNF-induced apoptosis, immune-mediated liver injury, viral clearance
- MeSH terms
- Animals, Hepatitis, Viral, Human, Humans, Liver, CD8-Positive T-Lymphocytes, Hepatocytes, Endothelial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.